Magnetic Resonance Imaging News and Research

RSS

Magnetic resonance imaging (MRI) is an imaging technique which physicians use for the diagnosis and treatment of medical conditions.

GE Healthcare's Magnetic Resonance Imaging receives 2011 IDEA awards

GE Healthcare, a unit of General Electric Company, today announced it received several Silver Awards from the 2011 International Design Excellence Awards for Magnetic Resonance Imaging by the Industrial Designers Society of America.

8 Jul 2011

Natural vitamin E may reduce brain damage after stroke

Ten weeks of preventive supplementation with a natural form of vitamin E called tocotrienol in dogs that later had strokes reduced overall brain tissue damage, prevented loss of neural connections and helped sustain blood flow in the animals' brains, a new study shows.

6 Jul 2011

Researchers predict human's desired movements using brain signals

Bringing the real world into the brain scanner, researchers at The University of Western Ontario from The Centre for Brain and Mind (http://www.uwo.ca/its/brain/) can now determine the action a person was planning, mere moments before that action is actually executed.

30 Jun 2011

New software program can allow scientists to produce single brain images

A University of Colorado Boulder research team has developed a new software program allowing neuroscientists to produce single brain images pulled from hundreds of individual studies, trimming weeks and even months from what can be a tedious, time-consuming research process.

28 Jun 2011

Redefinition of cardiac hypertrophy term needed

The European Society of Cardiology (ESC) Working Group on Myocardial Function is calling for a redefinition of the term cardiac hypertrophy which is currently used to describe changes to the morphology (structure) of the heart. Instead the position paper, published online today in the European Journal of Heart Failure, suggests that use of the general term myocardial remodelling should be preferred.

27 Jun 2011

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today the main results of the completed Phase I/II study of the new component Amphinex in the combination productPC-A11, where Amphinex is used in combination with the cytotoxic agent bleomycin.

24 Jun 2011

‘City slickers’ at increased brain stress: Study

German and Canadian neuroscientists have shown that living in a city or even being raised in one is associated with differences in the way the brain handles stress. They write in Nature that this is the first time researchers have used functional magnetic resonance imaging (fMRI) to identify specific brain regions that are affected by urban life.

23 Jun 2011

Autistic toddlers’ brain research may help early diagnosis: Study

Researchers have noted that the brain activities of toddlers with autism appears to be out of sync at a very early stage -- a finding that sheds light on the biology of the condition and might help in earlier diagnosis. The study was published in the journal Neuron.

23 Jun 2011

Self-perception of body traced to specialized multisensory neurons

By taking advantage of a "body swap" illusion, researchers have captured the brain regions involved in one of the most fundamental aspects of self-awareness: how we recognize our bodies as our own, distinct from others and from the outside world. That self-perception is traced to specialized multisensory neurons in various parts of the brain that integrate different sensory inputs across all body parts into a unified view of the body.

17 Jun 2011

European scientists develop efficient methods for early diagnosis of Alzheimer's

PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.

16 Jun 2011

Dual Body scan machine gets FDA nod

According to the U.S. Food and Drug Administration last Friday, Siemens AG's device that simultaneously performs two common diagnostic tests received clearance from them. The German engineering company's U.S.-based Siemens Medical Solutions, which is based in Pennsylvania, manufactures the device.

From Siemens Healthineers 13 Jun 2011

Daytime sleepiness influences brain's response to food and affects eating behavior

Daytime sleepiness may affect inhibitory control in the brain when viewing tantalizing, high-calorie foods, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

13 Jun 2011

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Siemens receives FDA clearance for Biograph mMR system to perform simultaneous PET/MRI scan

The U.S. Food and Drug Administration today cleared the Siemens Biograph mMR system, the first device to simultaneously perform a positron emission tomography scan, commonly known as PET scan, and a magnetic resonance imaging (MRI) scan.

From Siemens Healthineers 13 Jun 2011

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company, and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), components of the National Institutes of Health.

10 Jun 2011

Study finds brain differences in preschool children with symptoms of ADHD

In a study published today in the Clinical Neuropsychologist, researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD).

10 Jun 2011

Heart function may be affected in people with Type 2 diabetes as early as adolescence

Heart function may be affected in people with Type 2 diabetes as early as adolescence, according to a new study that will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston.

8 Jun 2011

Medizintechnik acquires BSD-2000/3D/MR integrated hyperthermia system

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that Dr. Sennewald Medizintechnik GmbH (Medizintechnik) has purchased BSD Medical's BSD-2000/3D/MR Hyperthermia System (BSD-2000/3D/MR).

6 Jun 2011

New UH Seidman Cancer Center center to offer latest treatments and technology

University Hospitals (UH) Seidman Cancer Center, Northeast Ohio's first and only freestanding cancer hospital, opens to patients on June 6. The ten-story, 150-bed cancer hospital will house the latest cancer-fighting treatments and technology – all in a patient-centered, healing-focused environment.

6 Jun 2011

Incyte's ruxolitinib Phase III trial data on myelofibrosis presented at ASCO 2011

Incyte Corporation announced today results from the global, pivotal Phase III clinical program of ruxolitinib in patients with myelofibrosis (MF) at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting.

6 Jun 2011